Hart & Patterson Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Hart & Patterson Financial Group's LLY Position: Q4 2024 in Review
Hart & Patterson Financial Group reduced its Eli Lilly (LLY) stake by 1.6% in Q4 2024, selling an estimated $10.8K and leaving 789 shares worth $609K. The position accounts for 0.3% of the portfolio, ranked #47.
Hart & Patterson Financial Group first reported a position in LLY in Q4 2023 and has held it in 5 quarters since. The position peaked at $711K in Q3 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.
- Hart & Patterson Financial Group held 789 shares of Eli Lilly worth $609K as of Q4 2024.
- Hart & Patterson Financial Group sold 13 Eli Lilly shares in Q4 2024, an estimated $10.8K.
- Eli Lilly made up 0.3% of Hart & Patterson Financial Group's portfolio in Q4 2024, its #47 holding.
- Hart & Patterson Financial Group first reported a position in Eli Lilly in Q4 2023 and has held it in 5 quarters since.
- Hart & Patterson Financial Group's Eli Lilly position peaked at $711K in Q3 2024.
- 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.
Based on Hart & Patterson Financial Group's 13F filing for Q4 2024, filed 14 Jan 2025.